Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease. - Bertin, Luisa; Barberio, Brigida; Gubbiotti, Alessandro; Bertani, Lorenzo; Costa, Francesco; Ceccarelli, Linda; Visaggi, Pierfrancesco; Bodini, Giorgia; Pasta, Andrea; Sablich, Renato; Urbano, Maria Teresa; Ferronato, Antonio; et al. (Journal of Clinical Medicine, 2024)